Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

People with psoriasis have more health problems, including autoimmune diseases, than those without it.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

Long COVID has severely affected a couple's health, finances, and social life.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

Psoriasis lesions have fewer and smaller oil glands, which might affect the condition's development.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Healing psoriatic plaques can cause unexpected hair growth.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Sebaceous gland atrophy and abnormal function may contribute to hair loss in psoriasis.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.